Searched for
IMMUNOTHERAPY AND TARGETED ONCOLOGY
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- GSK India plans big 'reinvention', MD Bhushan Akshikar revealsGlaxoSmithKline Pharmaceuticals is planning a major comeback in India. The company aims to double its revenue to ₹8,000 crore within the ne...
- AstraZeneca, Gilead vie for edge in race to treat tough breast cancerNew data from Europe's biggest oncology meeting reveals a high-stakes race for patients with a tough breast cancer. Astra and Daiichi's Dat...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccineRussia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...
- Dr. Reddy’s shares rise over 1% on strategic collaboration with Alvotech for Keytruda BiosimilarDr. Reddy’s Laboratories has partnered with global biotech firm Alvotech to co-develop and commercialize a biosimilar of Keytruda (pembroli...
- Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mnSun Pharmaceuticals will acquire Checkpoint Therapeutics for $355 million, bringing the FDA-approved anti-PD-L1 treatment for advanced cuta...
- Mankind Pharma partners with Innovent to aid cancer treatment in IndiaMankind Pharma has partnered with Innovent Biologics to bring sintilimab, a PD-1 immunotherapy, to India. The drug treats various cancers a...
- Aurigene reports promising phase-1 data for its CAR-T therapy against myelomaAurigene Oncology has announced promising phase-1 results for its novel CAR-T cell therapy, Ribrecabtagene autoleucel, in patients with mul...
- Immunotherapy can stall the growth of malignant cells in cervical cancer patients: StudyIn India, cervical cancer is the second most common in women, making up close to 18 per cent of the new cancer cases, the International Age...
- Centre of Excellence for cancer care and blood disorders at Amrita Hospital, FaridabadAmrita Hospital's Department of Hematology, Medical Oncology and BMT helps patients treat blood disorders, benign diseases, as well as bloo...
- Cellogen to bring next-gen cancer therapy to India"Chimeric Antigen Receptor cells represent a cutting-edge technology that holds great promise for cancer treatment. We are delighted to off...
- 'Obesity paradox' decoded: Being overweight increases risk of diabetes but helps improve survival in cancer patientsWHO estimates at least 2.8 million people die each year as a result of being overweight or obese.
- World Cancer Day: Immunotherapy can help patients suffering from carcinoma of the lungsImmunotherapy should be given as early as possible to achieve a lasting remission of the disease.
- Merck sees market for novel therapies, to focus on its oncology pipelineMerck is betting big on its oncology pipeline, in the field of immunotherapy that has come to define new-age cancer treatment.
- Glenmark, APC Therapeutics ink licensing pact for cancer drugUnder the terms of the agreement, Glenmark will license the product from APC Therapeutics and manage all clinical development, including re...
Load More
